Product image of Metformin Hydrochloride Sandoz Ltd (Metformin Hydrochloride) supplied by GNH India

Metformin Hydrochloride Sandoz Ltd

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformin Hydrochloride Sandoz Ltd (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Sandoz Ltd, is a Biguanide presented as a tablet for oral use. It lowers elevated blood glucose in adults with type 2 diabetes mellitus by decreasing hepatic glucose output and enhancing peripheral insulin sensitivity.

GNH India supplies Metformin Hydrochloride Sandoz Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides reliable logistics to meet the needs of healthcare providers across global markets.

Manufacturer / TM Owner

Sandoz Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformin Hydrochloride is used to manage disorders of glucose metabolism.

  • Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c levels.
  • Prediabetes (impaired glucose tolerance): delays progression to overt diabetes.
  • Polycystic ovary syndrome: helps improve insulin resistance and may restore ovulatory function.

How It Works

  • Metformin Hydrochloride acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which reduces hepatic gluconeogenesis. It also decreases intestinal glucose absorption and increases peripheral glucose uptake by enhancing insulin receptor signaling, leading to improved overall insulin sensitivity without stimulating insulin secretion.

Side Effects

Metformin Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, or flatulence.
  • Diarrhea: loose stools occurring especially after treatment initiation.
  • Metallic taste: transient alteration in taste perception.
  • Decreased appetite: reduced feeling of hunger.

Serious or Rare Side Effects

  • Lactic acidosis: a rare but life‑threatening accumulation of lactate.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Vitamin B12 deficiency: may develop with long‑term therapy.

Precautions & Warnings

When prescribing Metformin Hydrochloride, consider the following precautions.

  • Renal function: assess eGFR before starting and monitor periodically.
  • Hepatic function: avoid in patients with significant liver disease.
  • Cardiovascular status: use cautiously in acute heart failure.
  • Alcohol consumption: limit intake to reduce risk of lactic acidosis.
  • Concomitant drugs: review for interactions that may increase metformin levels.
  • Store at room temperature: keep in original container, protect from moisture.

Avoid Interactions

Metformin Hydrochloride can interact with several medicines; awareness of the interaction level is important.

Major Interactions (Avoid)

  • Iodinated contrast agents: can precipitate lactic acidosis; discontinue metformin before and after imaging.
  • Cimetidine: may increase metformin plasma concentrations.
  • Alcohol excess: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycaemia symptoms.
  • Diuretics (loop or thiazide): can affect renal clearance of metformin.
  • Other antidiabetic agents: may increase risk of hypoglycaemia when combined.

Frequently Asked Questions

Metformin Hydrochloride is an oral antidiabetic medication indicated for the management of type 2 diabetes mellitus. It is also employed in patients with prediabetes to delay progression to diabetes and, off‑label, in polycystic ovary syndrome to improve insulin resistance.

The drug reduces hepatic glucose production by inhibiting mitochondrial complex I, lowers intestinal glucose absorption, and enhances peripheral insulin sensitivity. These actions together lower fasting and post‑prandial blood glucose without stimulating insulin secretion.

Dosing is individualized. The prescribing clinician determines the appropriate dose based on the patient’s renal function, glycaemic targets, and tolerability. Metformin is typically started at a low dose and titrated upward as needed.

Metformin is classified as pregnancy category B, indicating that animal studies have not shown risk and there are no well‑controlled studies in pregnant women. It may be used when the potential benefit justifies the risk. Limited data exist for breastfeeding; caution and clinical judgment are advised.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with sulfonylureas, Metformin does not cause hypoglycaemia when used alone and is weight‑neutral or may promote modest weight loss. Unlike insulin, it is oral and does not require injection. Its cardiovascular safety profile is favourable, making it a first‑line choice in many guidelines.

Store the product at room temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Metformin is taken orally, usually as whole tablets swallowed with a glass of water. It is recommended to take the dose with meals to minimise gastrointestinal discomfort.

The most serious adverse events are lactic acidosis, which is rare but potentially fatal, and severe cutaneous reactions such as Stevens‑Johnson syndrome. Long‑term therapy may also lead to vitamin B12 deficiency, requiring periodic monitoring.

Metformin is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to the drug, and in those receiving iodinated contrast media without appropriate interruption.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT